Clinical Trial Update: A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy [Phase 3]

View source ↗

Summary

Phase 3 double-blind, placebo-controlled trial evaluating adjunctive aripiprazole to antidepressant therapy in major depressive disorder; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-07-19